CASI Pharmaceuticals Inc (NASDAQ:CASI) The is shaping up and I expect the next point of resistance to be at $2.25. At some point will take off and never look back. I think that day will come soon and those buying at these prices will be thanking me down the road. Oppenheimer analyst Leland Gershell recently raised the price target on to $6.00 (from $5.00) while maintaining Outperform rating and the CEO purchased 480000 shares in August owning more than 5 million shares. I think is heading higher from here and will make an excellent trade going forward.